Irucalantide is a peptide analog with aromatic and charged residues that create distinct conformational states. Researchers use it to examine β-turn formation, backbone flexibility, and peptide-protein recognition. The sequence supports folding analyses under varied solvent conditions. Its architecture suits comprehensive biophysical evaluation.
CAT No: R2501
CAS No:1631160-47-8
Synonyms/Alias:Irucalantide;1631160-47-8;irucalantide [INN];OV42G2O3SQ;HY-P5536;DA-54386;CS-0886413;L-Cysteinamide, N-acetyl-S-[[3,5-bis(mercaptomethyl)phenyl]methyl]-L-cysteinyl-L-seryl-L-phenylalanyl-(2S)-2-azetidinecarbonyl-L-tyrosyl-N6-(aminoiminomethyl)-L-lysyl-L-cysteinyl-L-alanyl-psi(CH2-NH)-L-histidyl-L-glutaminyl-L-alpha-aspartyl-L-leucyl-, cyclic (1-->7),(1-->13)-bis(thioether);
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More